Study 180105-01 (Montreal-Quebec)

Study for Volunteers in good health

 
 
 
 

Men

&

Women

AGE: 18 to 40 years old

BMI: 18.6 to 29.9 (inclusively)

Compensation up to:
$3,000 (can go up to $4,000)

This study is available to male and female volunteers.

This study involves a drug used for the emergency treatment of severe allergic reactions. The formulations involved are a solution for intramuscular (into the muscle) or subcutaneous (under the skin) injection and a sublingual tablet (that dissolves under the tongue).

The goals of this study are:
To evaluate how safe and how well tolerated a sublingual tablet is when administered as a single dose ranging from 10 mg to 50 mg;
To evaluate how much and how quickly the drug is taken up and eliminated by the body when administered as a sublingual tablet compared to an intramuscular or a subcutaneous injection.

For more information, contact our recruitment department at 1 866 262-7427.

Complete an application and our staff will contact you by phone to give you an an appointment for an interview.

The dates shown above and compensation amount may change.

 

A study with 5 stays at the clinic.

Period 1
Admission: Thu, Feb. 28, 19 (approx. 04:00 PM)
Departure: Fri, Mar. 01, 19 (approx. 05:00 PM)
Period 2
Admission: Mon, Mar. 04, 19 (approx. 04:00 PM)
Departure: Thu, Mar. 07, 19 (approx. 10:00 AM)
Period 3
Admission: Mon, Mar. 18, 19 (approx. 04:00 PM)
Departure: Thu, Mar. 21, 19 (approx. 10:00 AM)
Period 4
Admission: Mon, Apr. 01, 19 (approx. 04:00 PM)
Departure: Thu, Apr. 04, 19 (approx. 10:00 AM)
Period 5
Admission: Mon, Apr. 15, 19 (approx. 04:00 PM)
Departure: Thu, Apr. 18, 19 (approx. 10:00 AM)

This study is available to male and female volunteers.

This study involves a drug used for the emergency treatment of severe allergic reactions. The formulations involved are a solution for intramuscular (into the muscle) or subcutaneous (under the skin) injection and a sublingual tablet (that dissolves under the tongue).

The goals of this study are:
To evaluate how safe and how well tolerated a sublingual tablet is when administered as a single dose ranging from 10 mg to 50 mg;
To evaluate how much and how quickly the drug is taken up and eliminated by the body when administered as a sublingual tablet compared to an intramuscular or a subcutaneous injection.

For more information, contact our recruitment department at 1 866 262-7427.

Complete an application and our staff will contact you by phone to give you an an appointment for an interview.

The dates shown above and compensation amount may change.

Syneos HealthTM Mailing List

Sign up for our newsletter and be among the first to receive information on any new clinical study offers. By entering your email address below, you agree to receive information emails from Syneos Health. You may also provide your mobile phone number to be informed of future studies via text messaging.

You may unsubscribe at any time.

  • If you wish to receive personalized emails, fill in the fields below.
  • Leaving so soon?

    Please tell us the main reason why you did not sign up today: